NRX Pharmaceuticals Warrant (NRXPW)

• Market cap: $10.8K
• 1 day: -9.34%
• 5 days: -38.57%
• 1 month: -39.68%
• 3 months: -60.39%
• 6 months: -69.9%
• Year to date: -55.74%
• 1 year: -73.62%
• 5 years: -99.62%
• 10 years: -91.45%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.